medmix Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | no data |
| CEO ownership | n/a |
| Management average tenure | 2.6yrs |
| Board average tenure | 2.7yrs |
Recent management updates
Recent updates
CEO
medmix has no CEO, or we have no data on them.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Financial Officer | 3.3yrs | no data | 0.0048% CHF 16.6k | |
| Head of M&A | 2.6yrs | no data | no data | |
| Chief Legal Officer | no data | no data | 0.0023% CHF 8.0k | |
| Chief Human Resources & Sustainability Officer | no data | no data | no data | |
| Global Head of Business Unit Dental | 1.9yrs | no data | no data | |
| Global Head Business Segment Industry | no data | no data | no data | |
| Global Head Business Segment Beauty | no data | no data | no data | |
| Global Head Business Segment Drug Delivery | no data | no data | no data | |
| Head of Business Segment Surgery | no data | no data | no data |
2.6yrs
Average Tenure
56yo
Average Age
Experienced Management: MEDXZ's management team is considered experienced (2.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Director | 2.7yrs | CHF 144.00k | 0.0039% CHF 13.2k | |
| Director | less than a year | no data | no data | |
| Director | 2.7yrs | CHF 146.00k | 0.0015% CHF 5.2k | |
| Independent Vice Chairman of the Board | 3.3yrs | CHF 163.00k | 0.032% CHF 109.5k | |
| Independent Director | 2.7yrs | CHF 146.00k | 0.0015% CHF 5.2k | |
| Independent Chairman | 2.7yrs | CHF 302.00k | 0.0017% CHF 5.8k | |
| Director | 2.7yrs | CHF 146.00k | 0.0015% CHF 5.2k |
2.7yrs
Average Tenure
55yo
Average Age
Experienced Board: MEDXZ's board of directors are not considered experienced ( 2.7 years average tenure), which suggests a new board.
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/23 12:32 |
| End of Day Share Price | 2024/12/23 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
medmix AG is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Christoph Gretler | Credit Suisse |
| Eugen Perger | Research Partners AG |